Followers | 212 |
Posts | 13482 |
Boards Moderated | 0 |
Alias Born | 06/20/2022 |

Tuesday, February 13, 2024 4:05:36 PM
Recent FBLG News
- FibroBiologics Confirms Ability to Manufacture CybroCell™ for Degenerative Disc Disease and Cartilage Repair Programs from Existing CYWC628 Master Cell Bank • GlobeNewswire Inc. • 07/09/2025 12:30:00 PM
- FibroBiologics’ to Present at Exclusive Live Investor Webinar and Q&A Session on July 10 • GlobeNewswire Inc. • 07/07/2025 08:35:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/03/2025 08:03:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/16/2025 09:00:28 PM
- FibroBiologics Closes Third $5 Million Tranche of $25 Million Financing • GlobeNewswire Inc. • 06/16/2025 08:35:00 PM
- FibroBiologics to Present at the BIO International Convention 2025 • GlobeNewswire Inc. • 06/16/2025 01:50:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2025 08:00:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2025 11:30:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2025 11:16:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/09/2025 08:01:31 PM
- FibroBiologics Appoints Jason D. Davis, CPA, as Chief Financial Officer • GlobeNewswire Inc. • 06/09/2025 12:30:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 06/06/2025 07:13:25 PM
- FibroBiologics Presents at the Society for Investigative Dermatology Annual Meeting • GlobeNewswire Inc. • 05/16/2025 12:30:00 PM
- FibroBiologics Reports First Quarter 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/14/2025 08:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2025 08:01:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/05/2025 08:01:32 PM
- FibroBiologics Presenting at the ThymUS 2025 Meeting • GlobeNewswire Inc. • 04/29/2025 01:15:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/23/2025 10:05:38 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/23/2025 10:01:29 AM
- FibroBiologics to Present at The Cell & Gene Meeting on the Mediterranean • GlobeNewswire Inc. • 04/11/2025 12:30:00 PM
- FibroBiologics Unveils New and Expanded Houston Laboratory Space to Pursue Innovation and Breakthroughs in Fibroblast-Based Therapeutics • GlobeNewswire Inc. • 04/08/2025 12:30:00 PM
- FibroBiologics Announces Scientific Advancement in Confirmation Results of Brain Tissue Repair • GlobeNewswire Inc. • 04/02/2025 12:30:00 PM
- FibroBiologics Reports Full Year 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/31/2025 08:25:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2025 08:04:47 PM
FEATURED Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs • CLDI • Jul 7, 2025 9:00 AM
VAYK Discloses More Insider Buying Approaching 15 Million • VAYK • Jul 2, 2025 10:37 AM